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Three-dimensional lattices of reconstituted, poly-
merized type I collagen were subjected to partial
hydrolysis by organ culture ¯uid from human skin or
by various matrix metalloproteinases, including
matrix metalloproteinase-1 (interstitial collagenase),
-2 (72 kDa gelatinase A), -8 (neutrophil collagenase),
-9 (92 kDa gelatinase B), or -13 (collagenase 3).
Following partial digestion, human dermal ®bro-
blasts were incubated on the enzyme-treated or
control lattices and examined for ability to contract
the collagen lattice and synthesize type I procollagen.
Collagen lattices partially degraded by organ culture
¯uid were contracted by ®broblasts under conditions
in which control collagen lattices were not. On the
partially degraded collagen, ®broblasts synthesized
reduced amounts of type I procollagen (approxi-
mately 70% reduction). Puri®ed matrix metallo-
proteinases with collagenolytic activity duplicated
the effects of the human skin organ culture ¯uid,
although matrix metalloproteinases 8 and 13 were
less ef®cient than matrix metalloproteinase-1 (65% vs
40% and 18% reduction in type I procollagen pro-
duction for matrix metalloproteinases 1, 8, and 13,
respectively). Matrix metalloproteinases 2 and 9 were
without effect on intact collagen; however, when
collagen lattices were subjected to digestion by a
combination of matrix metalloproteinases 1 and 9,
fragments produced by matrix metalloproteinase-1
were further degraded by the gelatinase. Collagen
contraction and inhibition of procollagen synthesis
were both reduced. Matrix metalloproteinase-2 was
less effective than matrix metalloproteinase-9 in
clearing matrix metalloproteinase-1-generated frag-
ments. Matrix metalloproteinase-2 was also less
effective in preventing contraction and inhibiting the
downregulation of type I procollagen synthesis.
These observations suggest that in the presence of
high molecular weight fragments of type I collagen,
type I procollagen synthesis is inhibited. As these
fragments are processed further, there is less inhib-
ition of type I procollagen production. Key words:
collagen contraction/collagen fragments/collagen lattice/
collagenase/dermal ®broblast/gelatinase/matrix metallopro-
teinase/type I procollagen. J Invest Dermatol 119:122±129,
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amage to interstitial connective tissue, occurring
over years or decades, is thought to underlie the
rough, wrinkled appearance of severely photoaged
skin (Smith et al, 1962; Schwartz et al, 1989, 1993;
Maloney et al, 1992; Marks, 1992). Connective
tissue damage in photoaged skin re¯ects both increased collagen
destruction and decreased replacement of damaged connective
tissue with newly synthesized collagen. Collagen degradation results
from repeated upregulation of matrix metalloproteinases (MMP) in
response to ultraviolet (UV) irradiation from the sun (Fisher et al,
1996, 1997). The same UV irradiation that induces MMP
expression also transiently suppresses transcription of type I
procollagen genes (Fisher et al, 2000). Although acute UV exposure
transiently downregulates type I procollagen synthesis, procollagen
synthesis returns to baseline levels within 2±3 d following
exposure. It is generally believed that these transient alterations in
collagen metabolism are responsible, at least in part, for the
progressive changes in connective tissue structure/function that
characterize severe photodamage.
In addition to the transient reduction in type I procollagen
synthesis following acute UV irradiation, there is also a sustained
reduction in collagen synthesis in severely photodamaged skin,
independent of recent UV exposure. This is seen as a lack of tissue
staining for type I or type III procollagen in severely damaged
forearm (sun-exposed) skin in comparison with sun-protected hip
skin from the same individuals (Grif®ths et al, 1993; Talwar et al,
1995). Reduced immuno-staining in the forearm skin is accom-
panied by a reduction in type I procollagen protein (western
blotting) in the same tissue (Talwar et al, 1995). Mechanisms
underlying the sustained reduction in collagen synthesis are not
fully understood. In a recent study (Varani et al, 2001), it was
demonstrated that the number of cells actively synthesizing type I
procollagen mRNA and protein was reduced in severely damaged
forearm skin as compared with the corresponding sun-protected
hip skin. In spite of this, the number of cells capable of synthesizing
type I procollagen was not signi®cantly different between the two
sites. This was shown by removing cells from the tissue and
assessing type I procollagen synthesis in monolayer culture. It was
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shown in the same study that when type I collagen was fragmented
in vitro by exposure to a mixture of MMP from human skin, the
collagen fragments inhibited procollagen synthesis by dermal
®broblasts from either skin site. These results have led us to
hypothesize that damaged collagen in severely photoaged skin acts
in some manner to downregulate type I procollagen synthesis by
cells that are intrinsically capable of synthesizing this protein.
Human skin expresses a number of MMP capable of attacking
native ®brillar collagen, including MMP-1 (interstitial collagenase),
MMP-8 (neutrophil collagenase), and MMP-13 (collagenase 3)
(Bauer et al, 1977; Airola et al, 1997; Varani et al, 2000a). Enzymes
capable of further degrading the fragments produced by collage-
nolytic enzymes are also expressed in skin, including MMP-2
(72 kDa gelatinase A), MMP-9 (92 kDa gelatinase B) (Karelina et
al, 1993; Varani et al, 2000a), and MMP-13 (Mitchell et al, 1996;
Shapiro, 1998). At present, the extent of collagen damage needed
to produce an environment that is inhibitory to procollagen
synthesis, as well as the enzymes responsible for fashioning this
environment are not known. This study addresses these issues. It is
shown that type I procollagen synthesis is inhibited in the presence
of the high molecular weight fragments of type I collagen produced
by collagenolytic enzymes (principally, MMP-1). As the high
molecular weight fragments are processed further, inhibitory
capacity decreases.
MATERIALS AND METHODS
Human dermal ®broblasts Human dermal ®broblasts were prepared
from biopsies of neonatal foreskin as described previously (Varani et al,
1994). The use of discarded foreskin tissue was approved by the
University of Michigan Institutional Review Board. Fibroblasts were
grown in Dulbecco's modi®ed minimal essential medium of Eagle
supplemented with nonessential amino acids and 10% fetal bovine serum.
Growth was at 37°C in a humidi®ed atmosphere containing 5% CO2.
The cells were subcultured one to two times before use.
Human skin MMP preparation Sun-protected (buttock) skin from
volunteers was exposed to UV irradiation (2 3 minimal erythema dose).
One day later, four 4 mm biopsies were obtained from the irradiated
skin site. The skin biopsies were cut into small pieces (six to eight per
biopsy) and incubated for 72 h in 1.5 ml of Ca2+-supplemented
(1.4 mM, ®nal concentration) keratinocyte basal medium (KBM) (MA
Bioproducts; Walkersville, MD). Incubation was at 37°C and 5% CO2.
Previous studies have demonstrated that these culture conditions preserve
histologic structure and biochemical function of human skin for several
days (Varani et al, 1994). At the end of the incubation period, the
culture ¯uid was clari®ed by low-speed centrifugation and used as the
enzyme source. The participation of human subjects in this project was
approved by the University of Michigan Institutional Review Board, and
all subjects provided written informed-consent prior to their inclusion in
the study.
Human basal cell carcinoma tissue was used as a second source of
human skin organ culture ¯uid. Fresh tumor specimens obtained at
surgery were cut into 2 mm pieces, and 15±20 tissue pieces incubated
for 72 h in 1.5 ml of Ca2+-supplemented KBM. Incubation was at 37°C
and 5% CO2. At the end of the incubation period, the culture ¯uid was
handled exactly as above. The use of discarded tumor tissue was
approved by the University of Michigan Institutional Review Board.
Conditioned medium from UV-irradiated skin and conditioned
medium from basal cell tumor skin both contain large amounts of active
MMP-1 as well as small amounts of immuno-reactive MMP-8 (neutro-
phil collagenase) and MMP-13 (collagenase 3) (Fisher et al, 1996, 1997;
Varani et al, 2000a). Active forms of gelatinolytic enzymes (e.g., MMP-2
and MMP-9) are also present in these conditioned media. In normal
(control) skin maintained under the same conditions, collagenolytic
activity is not detectable, and only low levels of gelatinolytic activity
(MMP-2) are seen. Zymography with gelatin and b-casein was used in
this study to con®rm the presence of active as well as latent enzyme
forms, and to standardize individual enzyme preparations. Zymography
was carried out as described previously (Gibbs et al, 1999).
Puri®ed human MMP and other reagents Human MMP-1, MMP-
2, MMP-8, MMP-9, and MMP-13 were obtained from Calbiochem
(San Diego, CA). Human recombinant tissue inhibitor of
metalloproteinase-1 (TIMP-1) was also obtained from Calbiochem and
soybean trypsin inhibitor (SBTI) was obtained from Sigma (St Louis,
MO). MMP-1, puri®ed from human rheumatoid synovial ®broblasts as
the proenzyme form, appeared as a doublet at 52 kDa and 57 kDa in
b-casein zymography. MMP-8 was isolated from activated human
neutrophils. The enzyme appeared as a 68 kDa latent form on western
blots. MMP-13 was obtained as a recombinant protein encompassing the
proenzyme 60 kDa form. Activation of all three enzymes was
accomplished by exposure of the enzyme to 10 ng of trypsin for 45 min
at 37°C followed by inactivation of the trypsin with 100 ng of SBTI.
The two gelatinases (i.e., MMP-2 and MMP-9) were recombinant
proteins produced in mammalian cells. They were obtained as active
forms. In gelatin zymography, the active MMP-9 was seen as an 83 kDa
moiety. MMP-2 was detected as a moiety at approximately 66 kDa.
Preparation and degradation of polymerized collagen
lattices Three-dimensional lattices of reconstituted, polymerized
collagen were prepared as described previously (Bell et al, 1979). Rat tail
collagen (4.7 mg per ml in 1 M HCl) (BD Biosciences, Bedford, MA)
was diluted to 1 mg per ml (unless otherwise stated) in culture medium
consisting of serum-free, Ca2+-supplemented KBM. The collagen
solution was made isotonic by addition of an appropriate amount of
10 3 concentrated Hanks' balanced salt solution, and brought to pH 7.2.
The collagen was added to wells of a 24-well plate (0.5 ml per well) and
incubated for 2 h at 37°C, during which time a stiff lattice of
polymerized collagen formed.
Degradation of polymerized collagen lattices was achieved by exposing
the collagen to the human skin organ culture ¯uid or to the puri®ed
enzymes for varying periods of time at 37°C. Intact collagen lattices
exposed to buffer alone served as control. At the end of the incubation
period, the supernatant ¯uid from control or treated collagen lattices was
removed. Collagen fragments released into the supernatant ¯uid were
resolved by sodium dodecyl sulfate±polyacrylamide gel electrophoresis
(8.5% gel) and staining with Coomassie Brilliant Blue. The polymerized
collagen lattices (still intact) were then brie¯y exposed in sequence to
10 mM ethylenediamine tetraacetic acid (to inhibit further MMP action)
and 14 mM Ca2+ (to neutralize the ethylenediamine tetraacetic acid).
Following this, the lattices were rinsed exhaustively with Ca2+-supple-
mented KBM. (Note: although in these experiments, enzyme amounts
and incubation times were used that produced no difference in the gross
appearance of the collagen lattices as compared with collagen lattices not
exposed to enzymes, exposure to higher enzyme concentrations or
exposure for a longer period of time eventually resulted in decompos-
ition of the lattices.)
In certain experiments, the collagen was heated to 60°C for 5 min
prior to dilution in Ca2+-supplemented KBM. Following this, the heat-
denatured collagen (i.e., gelatin) was subjected to enzyme-mediated
degradation exactly as done with intact collagen lattices.
Scanning electron microscopy Intact and partially degraded collagen
lattices were ®xed by mixing with an equal volume of 4% Sorenson's
buffered glutaraldehyde. Post®xation in 1% osmium tetroxide buffered in
s-collidine was followed by en bloc staining with uranyl acetate.
Dehydration was in a graded series of ethanol, followed by critical point
drying from absolute ethanol through liquid carbon dioxide. Specimens
were then mounted on stubs and conductive-coated with gold in a dc
sputter coater. Following this, specimens were examined using an ISI
Supr IIIA scanning electron microscope.
Fibroblast attachment and spreading on collagen
lattices Fibroblasts at passages 2±3 were added to collagen lattices at a
®nal concentration of 8 3 104 cells per culture. For this, Ca2+-
containing KBM medium was further supplemented with a combination
of 0.1 ng epidermal growth factor per ml, 0.5 mg insulin per ml, and 2%
pituitary extract. At various times later, cell attachment was assessed by
removing and counting the nonattached cells. The lattices were then
¯ooded with 10% buffered formalin. Spreading was assessed
microscopically.
Collagen contraction and type I procollagen synthesis by ®broblasts
on intact and partially degraded collagen lattices Fibroblasts at
passages 2±3 were added to intact and enzyme-treated collagen lattices at
a ®nal concentration of 8 3 104 cells per culture. Ca2+-containing,
growth factor-supplemented KBM medium was used as culture medium.
Cells were incubated for 4 d, with fresh culture medium provided on
day 2. Collagen contraction was assessed by measuring the diameter of
the collagen lattice at day 2 or day 3 using a microscope with a
calibrated grid in the eyepiece. Collagen contraction in this assay
depends on ®broblasts binding to the collagen ®bers and pulling the
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®bers as the cells, themselves, undergo actin and myosin sliding ®lament-
mediated contraction (Kreiss and Birchmeier, 1980; Ehrlich et al, 1986).
After incubation for 3±4 d, culture ¯uid was removed and the collagen
lattices rinsed twice with Ca2+-supplemented KBM. Fresh culture
medium (Ca2+- and growth factor-supplemented KBM) was added to
the wells and incubated for a further 2 h. Culture ¯uids collected at the
end of the 2 h incubation period were assayed for type I procollagen by
enzyme-linked immunosorbent assay (Pan Vera Corp., Madison, WI).
The cells were then released from the collagen by sequential treatment
with a high concentration of a bacterial collagenase preparation (100 mg
of type I collagenase from Clostridium histolyticum for 2 h) and trypsin
(0.5% for 15 min) and counted with the aid of a particle counter. In
certain experiments, 1 ng transforming growth factor (TGF)-b per ml
was used in place of the other growth factors during the 2 h incubation
period.
RESULTS
Collagen fragmentation by enzymes in human skin organ
culture ¯uid In the ®rst series of experiments, human skin organ
culture ¯uid prepared as described in Materials and Methods was
examined for the capacity to fragment ®brillar type I collagen
lattices. Previously it has been demonstrated that organ culture ¯uid
from either UV-exposed skin or basal cell carcinomas contains large
amounts of active MMP-1 as well as smaller amounts of two other
collagenases (MMP-8 and MMP-13) and large amounts of active
gelatinolytic enzymes (both MMP-2 and MMP-9) (Fisher et al,
1996, 1997; Varani et al, 2000a). Figure 1 demonstrates the
fragmentation pattern seen after collagen digestion for 18 h at
37°C. It can be seen from this ®gure that skin organ culture ¯uid
was capable of fragmenting ®brillar collagen. The major
degradation products consisted of 3/4 and 1/4 size fragments,
consistent with the activity of mammalian collagenases. In addition
to the 3/4 and 1/4 size fragments, there were additional (minor)
cleavage products in the digest (Fig 1). The presence of additional
fragments is consistent with subsequent cleavage of the collagenase-
generated products by other enzymes present in the organ culture
¯uid, including MMP-2 and/or MMP-9. Digestion of intact
collagen for shorter periods of time, produced correspondingly less
fragmentation, but the fragmentation pattern was similar to that
shown in Fig 1. Collagen fragmentation by skin organ culture ¯uid
was also dose-responsive. Finally, it was demonstrated that collagen
fragmentation by human skin organ culture ¯uid was inhibited by
50 ng TIMP-1 per ml, but was not blocked by 10 mg SBTI per ml
(not shown).
Figure 2 demonstrates the scanning electron microscopic
appearance of an intact three-dimensional collagen lattice and a
collagen lattice after exposure to human skin organ culture ¯uid.
The intact collagen lattice consists of a ®ne network of intercon-
nected ®bers with no apparent breaks (Fig 2A). After partial
digestion (Fig 2B), the collagen lattice appears to have collapsed, as
evidenced by the lack of open space within the lattice. The collagen
®bers appear to be thicker than control ®bers, and numerous blunt,
fragmented, ®bers are visible. The fragments are more readily
observed at higher magni®cation (Fig 2C, arrows). In spite of ®ber
fragmentation and ®ber thickening, it is apparent from Fig 2(B,C)
that the matrix is still largely intact. The scanning electron
microscopic ®ndings are, therefore, consistent with the results
from sodium dodecyl sulfate±polyacrylamide gel electrophoresis
analysis (Fig 1) in that both indicate that high molecular weight
fragments remain after polymerized collagen is exposed to MMP in
human skin organ culture ¯uid.
Fibroblast-mediated collagen contraction and type I
procollagen production on intact and partially degraded
collagen lattices Collagen lattices were exposed to human skin
organ culture ¯uid as described above. In parallel, lattices were
exposed to organ culture ¯uid in the presence of either 50 ng
TIMP-1 per ml or 10 mg SBTI per ml. Following this, human
dermal ®broblasts (8 3 104 cells) were added to each lattice and
incubated for 4 d. Collagen contraction was assessed on days 2 or 3
and procollagen synthesis was determined on days 3 or 4.
Consistent with a recent report (Varani et al, 2001), dermal
®broblasts were able to induce contraction of the partially degraded
collagen lattice under conditions in which no contraction of intact
collagen occurred (Fig 3, upper panel). Associated with this was a
decrease in type I procollagen synthesis (approximately 70%
reduction) (Fig 3, lower panel). It can also be seen from Fig 3
that when collagen lattices were exposed to organ culture ¯uid in
the presence of TIMP-1 (50 ng per ml), contraction did not occur
Figure 1. Cleavage of type I collagen by human skin organ
culture ¯uid. Intact a1 and a2 chains of type I collagen are observed
in control collagen, and are decreased after exposure to either MMP-1
or human skin organ culture ¯uid. The loss of intact a1 and a2 chains is
accompanied by the appearance of 3/4 and 1/4 size fragments.
Additional fragments are present in the collagen preparation exposed to
the organ culture ¯uid, but these are minor. (The prominent band in the
center of the organ culture ¯uid lane is a product of the organ culture
¯uid.)
Figure 2. Scanning electron microscopic
appearance of an intact collagen lattice and a
lattice that has been partially degraded by
exposure to human skin organ culture ¯uid.
(A) The intact collagen lattice consists of a ®ne
network of interconnected ®bers with no apparent
broken ends. (B) After partial digestion, the
collagen lattice appears to have collapsed, and
there is less open space within the lattice.
Numerous blunt-ends, indicative of breaks in the
collagen chains, are apparent. (C) Breaks are more
easily seen at higher magni®cation (arrows).
Original magni®cation: (A,B) Scale bars: 30 mm,
(C) Scale bar: 50 mm.
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upon the addition of ®broblasts. Contraction of the collagen did
occur, however, when the collagen lattices were exposed to SBTI
(10 mg per ml) along with the culture ¯uid and then incubated with
®broblasts. This is of interest as there was little reduction (from
control levels) in the production of type I procollagen on collagen
lattices that had been exposed to TIMP-1 along with the culture
¯uid. In contrast, the addition of SBTI to the culture ¯uid failed to
prevent the reduction in type I procollagen elaboration (Fig 3;
lower panel).
Additional experiments were conducted in which 1 ng TGF-b
per ml was added to the culture medium in place of the other
growth factors during the ®nal 2 h incubation. TGF-b is a potent
stimulator of collagen production (Ignotz and Massague, 1986), and
our own preliminary studies with ®broblasts in monolayer culture
demonstrated that addition of 1 ng per ml TGF-b increased type I
procollagen production from 744 ng per 1 3 105 cells to 1837 ng
per 1 3 105 cells. In spite of this, the addition of TGF-b to
®broblasts on collagen lattices failed to overcome the inhibition in
procollagen production occurring in conjunction with fragmenta-
tion and contraction of the collagen. In this series of (®ve)
experiments, type I procollagen levels decreased from 321 6 50 ng
per ml in cells maintained on intact collagen lattices to
112 6 25 ng per ml in cells maintained on fragmented collagen.
The relative decrease (66%) in the presence of fragmented collagen
vs intact collagen was virtually identical to that seen when other
growth factors (epidermal growth factor, insulin, and pituitary
extract) were used instead of TGF-b (see Fig 3). The implication
of this is that inhibition of type I procollagen production does not
appear to re¯ect a loss of responsiveness to any one particular
procollagen-inducing stimulus.
Collagen fragmentation by MMP-1, MMP-8, and MMP-
13 In the next series of experiments, type I collagen lattices were
exposed to varying concentrations of puri®ed (and activated)
MMP-1, MMP-8, and MMP-13. Fragmentation patterns were
assessed at the end of the incubation period. As shown in Fig 4,
MMP-1 (400 ng per 0.5 mg of collagen in 0.5 ml) produced 3/4
and 1/4 size fragments from intact collagen. Additional studies (not
shown) demonstrated that fragmentation could be seen with
concentrations of MMP-1 as low as 50±100 ng per 0.5 mg of
collagen. Native ®brillar type I collagen was also exposed to MMP-
8 or MMP-13 under the same conditions as used with MMP-1.
The fragmentation pattern produced by MMP-8 was
indistinguishable from that produced by MMP-1. Virtually all of
the cleaved collagen was accounted for as fragments of 3/4 and 1/4
size (Fig 4). In contrast, multiple different size fragments were
produced from intact collagen by the action of MMP-13 (Fig 4).
This is consistent with the fact that MMP-13 has substantial
gelatinolytic activity, and, like the gelatinases, effectively degrades
collagen telopeptides (Mitchell et al, 1996; Shapiro, 1998).
Fibroblast function on collagen lattices damaged by
collagenolytic enzymes Collagen lattices were treated for 5 h
with an amount of MMP-1 (400 ng per 0.5 mg of collagen in
0.5 ml) suf®cient to release measurable 3/4 and 1/4 size fragments
into the buffer but not suf®cient to induce depolymerization of the
collagen lattice. Following enzyme treatment and subsequent
washing, human dermal ®broblasts (8 3 104 cells) were added to
each lattice and incubated for 4 d. Collagen contraction and type I
procollagen synthesis were determined as above. As seen in Fig 5
(upper panel), digestion of the collagen lattice with MMP-1 alone
was suf®cient to alter the structure of the lattice in such a manner
that it could be contracted by dermal ®broblasts. As shown in Fig 5
(lower panel), type I procollagen production was decreased when
dermal ®broblasts were cultured on lattices exposed to MMP-1
(approximately 65% reduction).
Fibroblasts were also incubated on intact collagen lattices or
lattices that had been partially degraded by exposure to MMP-8 or
MMP-13. Collagen degraded by MMP-8 behaved in a similar
fashion to MMP-1-degraded collagen. That is, it contracted over a
2 d period in the presence of 8 3 104 dermal ®broblasts and
Figure 3. Collagen contraction and type I procollagen synthesis
on partially degraded collagen lattices. Upper panel: contraction of
intact and partially degraded collagen by human dermal ®broblasts.
Collagen contraction was assessed at day 2 as described in Materials and
Methods. Values shown represent the average percent reduction in the
diameter of the collagen lattice 6 SEM based on ®ve separate
experiments. Lower panel: type I procollagen synthesis by human dermal
®broblasts on intact and partially degraded collagen lattices. Values
represent average nanograms of type I procollagen per ml 6 SEM based
on ®ve separate experiments. Prior to assay, culture media volumes from
the control and treated groups were adjusted to a common cell number.
Statistical signi®cance was determined by ANOVA, followed by paired-
group comparisons. *p < 0.05; **p < 0.01.
Figure 4. Fragmentation of intact type I collagen by MMP-1,
MMP-8, or MMP-13. This ®gure demonstrates the a1 and a2 chains
of intact type I collagen after exposure of the substrate to buffer alone
for 18 h (collagen). It also demonstrates the loss of intact a1 and a2
chains and the appearance of 3/4 and 1/4 size fragments after exposure
of the substrate to either MMP-1 or MMP-8 and the loss of intact a1
and a2 chains and the presence of multiple fragments after exposure of
the substrate to MMP-13.
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®broblasts synthesized reduced amounts of type I procollagen on
this substrate as compared with intact collagen lattices (Fig 5, upper
and lower panels); however, MMP-8 was less ef®cient than
MMP-1 in that a higher concentration of enzyme (750 ng of
MMP-8 vs 50±100 ng of MMP-1 per 0.5 mg of collagen) was
necessary to facilitate collagen contraction. Even then, collagen
contraction was not as complete. Furthermore, synthesis of type I
procollagen was reduced by approximately 40% on lattices
degraded by MMP-8 in contrast to the 65% reduction on collagen
degraded by MMP-1. In contrast to results with both MMP-1 and
MMP-8, there was no contraction of the MMP-13-degraded
collagen, even when the collagen was exposed to 1 mg of enzyme
for 18 h (Fig 5, upper panel). Correspondingly, there was a smaller
reduction (approximately 18%) in the amount of type I procollagen
elaborated on collagen that had been digested with MMP-13
(Fig 5, lower panel). It should be noted that, although overt
contraction of the collagen was not observed after exposure to
MMP-13, cells behaved differently on this substrate than on intact
collagen. Whereas on nondegraded collagen, ®broblasts maintained
their mechanically stressed, spindle-shaped morphology, the same
cells aggregated on the MMP-13-degraded collagen and had a
spherical shape.
Collagen fragmentation by MMP-1 in conjunction with
MMP-2 or MMP-9 In the next series of experiments, type I
collagen lattices were exposed to varying concentrations of puri®ed
MMP-1, MMP-2, and MMP-9. Fragmentation patterns were
assessed at the end of the incubation period. Consistent with the
above ®ndings, MMP-1 (400 ng per 0.5 mg of collagen in 0.5 ml)
produced 3/4 and 1/4 size fragments from intact collagen
(Fig 6A). In contrast, MMP-2 and MMP-9 at concentrations as
high as 1 mg per 0.5 mg of collagen were completely ineffective in
producing detectable breaks in the intact type I collagen molecule
when digestion was carried out for up to 18 h (Fig 6A).
Figure 6(B) demonstrates the capacity of MMP-2 and MMP-9
(400 ng per 0.5 mg of collagen in 0.5 ml) to degrade collagen that
has been heated to 60°C for 5 min (i.e., gelatin) prior to enzyme
treatment. Additional studies (not shown) demonstrated that both
gelatinases produced multiple fragments from the intact, but heat-
denatured a1 and a2 chains at concentrations as low as 10 ng of
enzyme per 0.5 mg of substrate.
Although neither MMP-2 nor MMP-9 was able to cleave intact
®brillar type I collagen, both enzymes were able to produce
additional degradation of the 3/4 and 1/4 size fragments produced
from intact collagen by MMP-1. This was demonstrated by
utilizing MMP-1 along with varying amounts of either of the two
gelatinases. At high concentrations (0.5±1.0 mg), both enzymes
degraded the two large fragments into smaller peptides. Lower
concentrations of MMP-2 and MMP-9 produced correspondingly
less digestion. Interestingly, when preparations of MMP-2 and
Figure 6. Cleavage of type I collagen by various MMP alone or in combination. (A) Cleavage of intact collagen. This ®gure demonstrates the
a1 and a2 chains of intact type I collagen after exposure of the substrate to buffer alone for 18 h. It also demonstrates the loss of intact a1 and a2
chains and the appearance of 3/4 and 1/4 size fragments after exposure of the substrate to MMP-1 but not MMP-2 or MMP-9. (B) Cleavage of heat-
denatured collagen (i.e., gelatin). This ®gure demonstrates the a1 and a2 chains of intact heat-denatured type I collagen after exposure of the substrate
to buffer alone for 18 h. Loss of intact a1 and a2 chains and the appearance of multiple smaller fragments are seen after exposure of the substrate to
MMP-2 or MMP-9 for 18 h. (C) Cleavage of intact collagen. This ®gure demonstrates the a1 and a2 chains of intact type I collagen after exposure of
the substrate to buffer alone for 18 h. The ®gure also demonstrates the loss of intact a1 and a2 chains and the appearance of 3/4 and 1/4 size
fragments after exposure of the substrate to MMP-1 for 18 h. Finally, the ®gure demonstrates the ability of MMP-9 (and, to a lesser extent, MMP-2)
to induce further degradation of the 3/4 and 1/4 size fragments generated by MMP-1.
Figure 5. Collagen contraction and inhibition of type I
procollagen synthesis on collagen lattices exposed to MMP-1,
MMP-8, or MMP-13. Upper panel: collagen contraction was assessed at
day 2 as described in Materials and Methods. Values shown represent the
average percent reduction in the diameter of the collagen lattice 6 SEM
based on ®ve separate experiments. Lower panel: type I procollagen
synthesis. Values represent average nanograms of type I procollagen per
ml 6 SEM based on ®ve separate experiments. Prior to assay, culture
media volumes from the control and treated groups were adjusted to a
common cell number. Statistical signi®cance was determined by ANOVA,
followed by paired-group comparisons. *p < 0.05; **p < 0.01.
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MMP-9 were standardized with one another for gelatin-degrading
capacity, MMP-9 was more effective than MMP-2 in degrading
the 3/4 and 1/4 size fragments produced by the action of MMP-1
on intact type I collagen (Fig 6C). On a per microgram of enzyme
basis, MMP-9 was 4±6-fold more effective than MMP-2 in further
degrading MMP-1-generated collagen fragments.
Fibroblast function on collagen lattices damaged by MMP-1
in conjunction with MMP-2 or MMP-9 Collagen lattices
were treated for 5 h with MMP-1 as described above. Additional
lattices were treated with MMP-2 and MMP-9 at concentrations as
high as 1 mg per lattice, and still others were treated with a
combination of MMP-1 (400 ng) and either MMP-2 or MMP-9
(100 ng of each). Following enzyme treatment and subsequent
washing, human dermal ®broblasts (8 3 104 cells) were incubated
on the lattices, and collagen contraction and type I procollagen
synthesis determined as above. As seen in Fig 7 (upper panel),
digestion of the collagen lattice with MMP-1 alone was suf®cient
to alter the structure of the lattice in such a manner that it could be
contracted by dermal ®broblasts. In contrast, neither MMP-2 nor
MMP-9 duplicated the action of MMP-1. Collagen lattices
exposed to a combination of MMP-1 and MMP-2 were
contracted to a similar extent by dermal ®broblasts as collagen
lattices exposed to MMP-1 alone (Fig 7, upper panel), but
interestingly, collagen lattices exposed to a combination of
MMP-1 and MMP-9 did not fully contract (Fig 7, upper panel).
Type I procollagen synthesis by ®broblasts on intact and partially
degraded collagen lattices was assessed. As shown in Fig 7 (lower
panel), type I procollagen production was decreased when dermal
®broblasts were cultured on lattices exposed to MMP-1 (approxi-
mately 65% reduction), but not when the cells were cultured on
lattices exposed to MMP-2 or MMP-9 in the absence of MMP-1.
When dermal ®broblasts were incubated on lattices exposed to a
combination of MMP-1 and MMP-2, type I procollagen synthesis
was decreased to virtually the same level as seen on lattices exposed
to MMP-1 alone. When dermal ®broblasts were incubated on
collagen lattices exposed to MMP-1 in combination with MMP-9,
however, less inhibition of type I procollagen production was
observed (Fig 7, lower panel). Thus, there was a correlation
between the presence of high molecular weight collagen fragments
(including, but not necessarily limited to, the 3/4 and 1/4 size
fragments produced by the action of MMP-1) in the lattice,
collagen contraction in the presence of dermal ®broblasts and
decreased type I procollagen synthesis by the same cells.
Attachment and spreading of ®broblasts on intact and
partially degraded collagen As it was not possible to achieve
complete digestion of the collagen in the lattices (without the
collagen lattices depolymerizing), it is dif®cult to know for sure if
the added ®broblasts attach to collagen fragments or to the
remaining intact ®bers. One would assume that at least some of the
added cells must attach to the damaged ®bers as when the ®bers are
further digested, collagen contraction does not occur and
procollagen synthesis is not decreased. To address this issue
directly, the following experiment was carried out. Collagen
lattices were prepared in the normal manner and either maintained
as is, or treated with MMP-1 to convert approximately 50% of the
collagen chains to 3/4 and 1/4 size fragments (i.e., 5 h digestion
with 400 ng of enzyme per 0.5 mg of collagen in a 0.5 ml volume).
In parallel, collagen lattices were prepared containing only 50% of
the collagen normally used in the lattices. Fibroblast attachment and
spreading were assessed on the three substrates. Cells attached
rapidly to all three lattices, and there was no differences among
them (Fig 8, upper panel). It can be seen from the lower panel,
however, that cells spread rapidly on the intact lattices (at both
Figure 7. Collagen contraction and inhibition of type I
procollagen synthesis on collagen lattices exposed to MMP-1
and/or MMP-2 or MMP-9. (A) Collagen contraction was assessed at
day 2 as described in Materials and Methods. Values shown represent the
average percent reduction in the diameter of the collagen lattice 6 SEM
based on ®ve separate experiments. (B) Type I procollagen synthesis.
Values represent average nanograms of type I procollagen per ml 6 SEM
based on ®ve separate experiments. Prior to assay, culture media volumes
from the control and treated groups were adjusted to a common cell
number. Statistical signi®cance was determined by ANOVA, followed by
paired-group comparisons. *p < 0.05; **p < 0.01, ***p < 0.001.
Figure 8. Fibroblast attachment and spreading on intact and
collagenase-damaged collagen lattices. Collagen lattices were
prepared with 0.5 or 0.25 mg of collagen per 0.5 ml volume. Collagen
fragmentation was accomplished by exposing lattices to MMP-1 (400 ng
of enzyme per 0.5 mg of collagen for a 5 h period). Following this,
®broblasts were added to the collagen lattices. Attachment and spreading
were assessed at various times later as indicated in Materials and Methods.
Values shown represent the percentage of cells that were attached and
the percentage spread 6 differences between individual values and
averages at each time-point in two separate experiments.
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collagen concentrations). Spreading was retarded, however, on the
lattices exposed to MMP-1.
DISCUSSION
Synthesis of type I procollagen is reduced in severely photo-
damaged skin (Grif®ths et al, 1993; Talwar et al, 1995). Based on
observations published in a recent report (Varani et al, 2001), it was
speculated that damaged collagen, itself, acts in some manner to
inhibit new collagen synthesis. It is demonstrated in the present
report that type I procollagen synthesis is reduced in vitro in the
presence of high molecular weight fragments of type I collagen.
When the fragments, which are generated by the action of
collagenolytic MMP on intact ®brillar type I collagen, are degraded
further by exposure to MMP with gelatinolytic activity, procolla-
gen production is restored.
Although all three mammalian collagenases are able to attack
native, ®brillar type I collagen, MMP-1 is likely to be the enzyme
in organ cultures of human skin responsible for most of the collagen
damage in vitro. MMP-1 was more ef®cient than the other two
collagenases in producing collagen damage (both in terms of
enzyme concentration needed to produce measurable damage and
in terms of the maximal decrease in subsequent procollagen
synthesis by ®broblasts on the collagenase-treated substrate). MMP-
1 is also likely to be the major enzyme responsible for collagen
damage in photoaged skin in vivo. MMP-1 is the major
collagenolytic enzyme present in human skin (Bauer et al, 1977).
Furthermore, it is present in the active form, whereas MMP-8 and
MMP-13 are present mostly as latent forms (Varani et al, 2000a).
Finally, MMP-1 is upregulated in response to UV irradiation
(Fisher et al, 1996, 1997) as well as a consequence of chronologic
aging (Varani et al, 2000b). The time courses for MMP-1
upregulation and collagen fragmentation in skin are closely
correlated (Fisher et al, 2001).
Not surprisingly, the two gelatinases were unable to affect any
measurable change in the collagen lattice by themselves. Although
the gelatinases were unable to duplicate the effects of the
collagenases, these enzymes, in particular, MMP-9, were able to
modify the effects of treatment with MMP-1 alone. Speci®cally,
when intact collagen was exposed to a combination of MMP-1 and
MMP-9, the 3/4 and 1/4 size fragments produced by the action of
MMP-1 were further degraded to smaller peptides. This is of
interest because when ®broblasts were incubated on these collagen
lattices, they induced less collagen lattice contraction and
synthesized correspondingly greater amounts of type I procollagen
than they did when incubated on collagen lattices exposed to
MMP-1 alone. It should be noted that, whereas these studies are
the ®rst to demonstrate a bene®cial role for MMP-9 in human skin
pathophysiology, previous studies with MMP-9 gene-deleted mice
have shown bene®cial effects of MMP-9 on recovery from
in¯ammatory injury. Speci®cally, Wang et al (1999) demonstrated
that resolution of contact-sensitivity was slower in MMP-9-
de®cient mice than in control mice. Thus, MMP-9 may function
in a number of settings to remove damaged connective tissue so
that return to normal structure/function can occur.
Taken together, the ®ndings presented in this study provide
insight into possible mechanisms by which damaged collagen
in¯uences procollagen synthesis. The ®ndings suggest, ®rst of all,
that the reduction in procollagen elaboration in the presence of
damaged collagen is related to decreased mechanical tension on the
cells. Decreased mechanical tension, evidenced by a loss of the
stretched, spindle-shape morphology and conversion to a spherical
shape, was seen both in contracted collagen (following MMP-1 or
MMP-8 treatment) and in noncontracted collagen degraded by
MMP-13. Whether the reduction in mechanical tension on the
cells is causally related to reduced type I procollagen production is
not known with certainty. Consistent with the suggestion that it is,
previous studies have demonstrated that when ®broblasts are
allowed to contract intact collagen (i.e., by using a high ratio of
cells to collagen substrate and by physically detaching the collagen
substrate from the wall of the culture dish; Zhu et al, 2001) matrix
synthesis is reduced. Likewise, it has been previously demonstrated
that applying a pulsatile stress to stromal cells on a stretchable
membrane results in increased matrix synthesis concomitant with
increased tension (Riser et al, 1992). Finally, the observation of a
substantially higher level of procollagen production by ®broblasts in
monolayer culture than by the same cells on collagen gels (this
study) is also consistent with this idea. With these observations in
mind, we suggest that collagen ®bers that have been fragmented by
collagenolytic enzymes allow for ®broblast attachment (known
from previous studies; Messent et al, 1998) as well as our own
observations (Fig 8), but do not support ®broblasts in the physically
stressed condition needed for optimum procollagen elaboration.
When the collagenase-damaged ®bers are degraded further and
cleared, then ®broblasts have only the remaining intact collagen to
attach to, and contraction is resisted. What makes these ®ndings of
interest is that biochemical and ultrastructural studies have dem-
onstrated similar damage to collagenous ®bers in photodamaged
skin and a concomitant loss of the spindle-shaped ®broblast
morphology (Fisher et al, 2001; Varani et al, 2001). Thus, far from
being an ``in vitro effect'', damaged collagen appears to produce a
similar loss of mechanical tension in resident dermal ®broblasts in
photodamaged skin to that observed in vitro. The reduction in
procollagen production characteristically observed in photoda-
maged skin (Grif®ths et al, 1993; Talwar et al, 1995) may therefore
re¯ect a similar mechanism as identi®ed in these in vitro studies.
This scenario is able to explain the differential procollagen-
inhibiting activity seen in the presence of high molecular weight
collagen fragments vs the effects seen when these fragments are
digested to smaller peptides and (presumably) cleared. This is not
meant to imply, however, that inhibition of procollagen synthesis
only occurs as a result of ®broblasts binding to damaged ®bers. If
there is suf®cient overall damage to the lattice, ®broblasts
undoubtedly contract the remaining intact ®bers, with a concomi-
tant reduction in procollagen synthesis.
How the reduction in physical stress on the cells contributes to
lowered matrix production is not fully understood. When
®broblasts undergo relaxation, the surface area to volume is
reduced as the cells develop a spherical shape. Numerous microvilli
form in the plasma membrane to accommodate excess membrane
material. It would not be unreasonable to suggest that procollagen-
inducing ligands either cannot interact with relevant cell surface
receptors effectively, or if they do, that such interactions fail to
generate the proper signals. Past studies have provided direct
evidence in support of this. Speci®cally, it has been shown that
signaling through mitogen-activated protein kinase pathways in
®broblasts depends on the cells being attached and spread on a
substratum. In the absence of this, receptor autophosphorylation is
reduced (Lin and Grinnell, 1993), activation of downstream
intermediates such as extracellular signal-regulated kinase is
decreased (Boudreau and Jones, 1999), and translocation of
phosphorylated extracellular signal-regulated kinase to the nucleus
does not occur (Aplin et al, 2001). Together, these de®ciencies
could be expected to inhibit the transcription of genes (for
example, type I procollagen) that depend on mitogen-activated
protein kinase signaling and activation of related transcription
factors.
It is of interest to note in this regard that reduction in
procollagen synthesis does not appear to re¯ect a loss of respon-
siveness to any one speci®c collagen-inducing stimulus. Whereas
most of our studies were done with a combination of epidermal
growth factor, insulin, and pituitary extract as procollagen inducers,
experiments were also carried out in which TGF-b was used to
enhance procollagen production in place of the other factors. As
expected, ®broblasts elaborated substantially more type I procolla-
gen in the presence of TGF-b than in its absence (observed with
®broblasts in monolayer culture). Consistent with past ®ndings
(Clark et al, 1995), however, when TGF-b was added to ®broblasts
in contracted collagen lattices, procollagen production decreased,
just as it did in the absence of TGF-b.
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In summary, studies carried out here demonstrate that ®broblast
production of type I procollagen is reduced in the presence of
collagenase-degraded collagen. Clearing of the collagen fragments
by MMP-9 reverses the downregulation of type I procollagen
synthesis. As it has already been demonstrated that collagen
breakdown products are present in severely photodamaged skin
(Fisher et al, 2001; Varani et al, 2001), the present data allow us to
speculate that damage to the extracellular matrix (occurring over
years or decades) and failure to clear completely the damaged
fragments gives rise to a matrix in which ®broblast synthesis of new,
replacement collagen is retarded. With this in mind, strategies for
preventing or reversing the consequences of repeated, chronic sun
exposure should include ways to clear damaged collagen in addition
to preventing its breakdown initially.
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